Reverse iontophoresis of L-lactate: In vitro and in vivo studies
Corresponding Author
M.B. Delgado-Charro
Department of Pharmacy and Pharmacology, University of Bath, Bath, UK
Department of Pharmacy and Pharmacology, University of Bath, Bath, UK. Telephone: +44-1225 383969; Fax: 44-1225 386114Search for more papers by this authorRichard H. Guy
Department of Pharmacy and Pharmacology, University of Bath, Bath, UK
Search for more papers by this authorCorresponding Author
M.B. Delgado-Charro
Department of Pharmacy and Pharmacology, University of Bath, Bath, UK
Department of Pharmacy and Pharmacology, University of Bath, Bath, UK. Telephone: +44-1225 383969; Fax: 44-1225 386114Search for more papers by this authorRichard H. Guy
Department of Pharmacy and Pharmacology, University of Bath, Bath, UK
Search for more papers by this authorAbstract
This work investigates the reverse iontophoretic extraction of lactate, a widely used marker of tissue distress in critically ill patients and of sports performance. In vitro experiments were performed to establish the relationship between subdermal lactate levels and lactate iontophoretic extraction fluxes. Subsequently, the iontophoretic extraction of lactate was performed in vivo in healthy volunteers. Lactate was quickly and easily extracted by iontophoresis both in vitro and in vivo. During a short initial phase, iontophoresis extracts the lactate present in the skin reservoir, providing information of relevance, perhaps, for dermatological and cosmetic applications. In a second step, lactate is extracted from the interstitial subdermal fluid allowing local lactate kinetics to be followed in a completely non-invasive way. The simultaneous in vivo extraction of chloride, and its possible role as an internal standard to calibrate lactate reverse iontophoretic fluxes, was also demonstrated. Despite these positive findings, however, considerably more research is necessary to eliminate potential artefacts and to facilitate interpretation of the data. © 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 96: 3457–3465, 2007
REFERENCES
- 1Leverve XM. 1999. Energy metabolism in critically ill patients: Lactate is a major oxidizable substrate. Curr Opin Clin Nutr Metab Care 2: 165–169.
- 2Mizock BA. 1997. Significance of hyperlactatemia without acidosis during hypermetabolic stress. Crit Care Med 25: 1780–1781.
- 3Klaus S, Heringlake M, Gliemroth J, Pagel H, Staubach K, Bahlmann L. 2003. Biochemical tissue monitoring during hypoxia and reoxygenation. Resucitation 56: 299–305.
- 4Mizock BA. 1995. Alterations in carbohydrate metabolism during stress: A review of the literature. Am J Med 98: 75–84.
- 5Kellum JA. 1998. Lactate and pHi: Our continued search for markers of tissue distress. Crit Care Med 26: 1783–1784.
- 6De Baker D, Vincent JL. 2000. Monitorage de taux de lactate sanguine en réanimation. Annales de Biologie Clinique 58: 487–490.
- 7Mizock BA. 1998. Lactate and point of care testing. Crit Care Med 26: 1474–1476.
- 8Boldt J, Kumle B, Stuttner S, Haisch G. 2001. Point-of-care (POC) testing of lactate in the intensive care patient. Accuracy, reliability, and costs of different measurements systems. Acta Anaesthesiol Scand 45: 194–199.
- 9Wilson M, Davis DP, Coimbra R. 2003. Diagnosis and monitoring of hemorrhagic shock during the initial resuscitation of multiple trauma patients: A review. J Emerg Med 24: 413–422.
- 10Mizock BA, Falk JL. 1992. Lactic acidosis in critical illness. Crit Care Med 20: 80–93.
- 11Ogedegbe AEO, Thomas DL, Diehl AM. 2003. Hyperlactataemia syndromes associated with HIV therapy. Lancet Infect Dis 3: 329–337.
- 12Mina J, Simon M. 2002. Hyperlactatemia syndromes in people with HIV infection. Curr Opin Infect Dis 15: 23–29.
- 13Slomovitz B, Lavery R, Tortella B, Siegel J, Bahl B, Ciccone A. 1998. Validation of a hand-held lactate device in determination of blood lactate in critically injured patients. Crit Care Med 26: 1523–1528.
- 14Weinstein DA, Wolfsdorf JI. 2002. Glycogen storage diseases: A primer for clinicians. Endocrinologist 12: 531–538.
- 15Billat VL, Sirvent P, Py G, Koralsztein JP, Mercier J. 2003. The concept of maximal lactate steady state. Sports Med 33: 407–426.
- 16Bishop D, Jenkins DG, Mackinnon LT. 1998. The relationship between plasma lactate parameters, Wpeak and 1-h cycling performance in women. Med Sci Sports Exerc 30: 1270–1275.
- 17Gfrerer RJ, Brunner GA, Trajanoski Z, Schaupp L, Sendlhofer G, Skrabal F, Jobst G, Moser I, Urban G, Urban TR, Pieber TR, Wach P. 1998. Novel system for real-time ex vivo lactate monitoring in human whole blood. Biosens & Biolectr 13: 1271–1278.
- 18Poscia A, Messeri D, Moscone D, Ricci F, Valgimigli F. 2005. A novel continuous subcutaneous lactate monitoring system. Biosens Biolectr 20: 2244–2250.
- 19Rajamand Ekberg N, Wisniewski N, Brisnar K, Ungerstedt U. 2005. Measurement of glucose and metabolites in subcutaneous adipose tissue during hyperglycemia with microdialysis at various perfusion rates. Clin Chim Acta 359: 53–64.
- 20Leboulanger B, Guy RH, Delgado-Charro MB. 2004. Reverse iontophoresis for non-invasive transdermal monitoring. Physiol Meas 25: R35–R50.
- 21Pitzer KR, Desai S, Dunn T, Edelman S, Jayalakshmi Y, Kennedy J, Tamada JA, Potts RO. 2001. Detection of hypoglycaemia with the GlucoWatch Biographer. Diabet Care 24: 881–885.
- 22Sieg A, Guy RH, Delgado-Charro MB. 2004. Non-invasive glucose monitoring by reverse iontophoresis in vivo: Application of the internal standard concept. Clin Chem 50: 1383–1390.
- 23Sieg A, Guy RH, Delgado-Charro MB. 2003. Reverse iontophoresis for non-invasive glucose monitoring: the internal standard concept. J Pharm Sci 92: 2295–2302.
- 24Leboulanger B, Aubry JM, Gondolfi G, Guy RH, Delgado-Charro MB. 2004. Non-invasive lithium monitoring by reverse iontophoresis in vivo. Clin Chem 50: 2091–2100.
- 25Gaskill SE, Ruby BC, Walker AJ, Sanchez OA, Serfass RC, Leon AS. 2001. Validity and reliability of combining three methods to determine ventilatory threshold. Med Sci Sports Exerc 33: 1841–1848.
- 26Glikfeld P, Cullander C, Hinz RS, Guy RH. 1988. A new system for in vitro studies of iontophoresis. Pharm Res 5: 443–446.
- 27Haschke-Becher E, Baumgartner M, Bachmann C. 2000. Assay of D-lactate in urine of infants and children with reference values taking into account data below detection limit. Clin Chim Acta 298: 99–109.
- 28Marti R, Varela E, Segura RM, Alegre J, Suriñach JM, Pascal C. 1997. Determination of D-lactate by enzymatic methods in biological fluids: Study of interferences. Clin Chem 43: 1010–1015.
- 29Rao G, Guy RH, Glikfeld P, LaCourse WR, Leung L, Tamada J, Potts RO, Azimi N. 1995. Reverse iontophoresis: Non-invasive glucose monitoring in vivo in humans. Pharm Res 12: 1869–1873.
- 30Sieg A, Guy RH, Delgado-Charro MB. 2004. Simultaneous extraction of urea and glucose by reverse iontophoresis in vivo. Pharm Res 21: 1805–1815.
- 31Johnson JA, Fusaro RM. 1972. The role of the skin in carbohydrate metabolism. Adv Metab Disord 6: 1–55.
- 32Caspers PJ, Lucasen GW, Carter EA, Bruining HA, Puppels GJ. 2001. In vivo confocal raman microspectroscopy of the skin: Noninvasive determination of molecular concentration profiles. J Invest Dermatol 116: 434–442.
- 33Nakagawa N, Sakai S, Matsumoto M, Yamada K, Pagano N, Auki T, Sumida Y, Uchiwa H. 2004. Relationship between NMF (lactate and potassium) cont and the physical properties of the stratum corneum in healthy subjects. J Invest Dermatol 122: 755–763.
- 34Jokura Y, Ishikawa S, Tokuda H, Imokawa G. 1995. Molecular analysis of elastic properties of the stratum corneum by solid-state 13C-nuclear magnetic resonance spectroscopy. J Invest Dermatol 104: 806–812.
- 35Kobayashi M, Takatori T, Nakajima M, Saka K, Iwase H, Nagao M, Niijima H, Matsuda Y. 1999. Does the sequence of onset of rigor mortis depend on the proportion of muscle fibre types and on intra-muscular glycogen content? Int J Legal Med 112: 167–171.
- 36Kobayashi M, Takatori T, Iwadate K, Nakajima M. 1996. Reconsideration of the sequence of rigor mortis through post-mortem changes in adenosine nucleotides and lactic acid in different rat muscles. Forensic Sci Int 82: 243–253.
- 37Leboulanger B, Fathi M, Guy RH, Delgado-Charro MB. 2004. Reverse iontophoresis as a non-invasive tool for lithium monitoring and pharmacokinetic profiling. Pharm Res 21: 1214–1222.
- 38Leboulanger B, Guy RH, Delgado-Charro MB. 2004. Non-invasive monitoring of phenytoin by reverse iontophoresis. Eur J Pharm Sci 22: 427–433.
- 39Ellmerer M, Schaupp L, Sendholfer G, Wute A, Brunner GA, Trajanosi Z, Skrabal F, Wach P, Pieber TR. 1998. Lactate metabolism of subcutaneous adipose tissue studied by open flow microperfusion. J Clin Endocrinol Metab 83: 4394–4401.
- 40Hagstrom E, Arner P, Ungerstedt U, Bolinder J. 1990. Subcutaneous adipose tissue: a source of lactate production after glucose ingestion in humans. Am J Physiol 258: E888–E893. (Endocrinol. Metab. 27)
- 41Hagstrom-Toft E, Enoksson S, Moberg E, Bolinder J, Arner P. 1997. Absolute concentrations of glycerol and lactate in human skeletal muscle, adipose tissue, and blood. Am J Physiol 273: E584–E592. (Endocrinol. Metab. 36)
- 42Burnette RR, Ongipipattanakul B. 1987. Characterization of the permselective properties of excised human skin during iontophoresis. J Pharm Sci 76: 765–773.